Your browser doesn't support javascript.
loading
Reliability of extracellular contrast versus gadoxetic acid in assessing small liver lesions using liver imaging reporting and data system v.2018 and European association for the study of the liver criteria.
Rimola, Jordi; Sapena, Víctor; Brancatelli, Giuseppe; Darnell, Anna; Forzenigo, Laura; Mähringer-Kunz, Aline; Paisant, Anita; Renzulli, Matteo; Schima, Wolfgang; Terraz, Sylvain; Valls, Carlos; Wagner, Mathilde; Ayuso, Carmen; Vilgrain, Valerie; Reig, Maria; Ronot, Maxime.
  • Rimola J; BCLC Group, Radiology Department, Hospital Clínic Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Sapena V; IDIBAPS, Statistics Core, Barcelona, Spain.
  • Brancatelli G; Dipartimento di Biomedicina, Neuroscienze e Diagnostica avanzata (BIND), University Hospital of Palermo, Palermo, Italy.
  • Darnell A; BCLC Group, Radiology Department, Hospital Clínic Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Forzenigo L; Radiology Department, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Mähringer-Kunz A; Department of Diagnostic and Interventional Radiology, University Medical Center Mainz, Mainz, Germany.
  • Paisant A; Radiology Department, Angers University Hospital, UNIV Angers, HIFIH, EA, Angers, France.
  • Renzulli M; Department of Radiology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Schima W; Department of Diagnostic and Interventional Radiology, Barmherzige Schwestern Krankenhaus, and Sankt Josef Krankenhaus, Göttlicher Heiland Krankenhaus, Vienna, Austria.
  • Terraz S; Department of Radiology, Hepato-Pancreato-Biliary Centre, University Hospitals of Geneva, Geneva, Switzerland.
  • Valls C; Department of Radiology, Karolinska University Hospital, Division of Radiology, CLINTEC, Karolinska Institutet, Stockholm, Sweden.
  • Wagner M; Sorbonne Université, INSERM, CNRS, LIB, Department of Radiology, Hôpitaux Universitaires Pitié-Salpêtrière-Charles Foix, APHP, Paris, France.
  • Ayuso C; BCLC Group, Radiology Department, Hospital Clínic Barcelona, Barcelona, Spain.
  • Vilgrain V; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), University of Barcelona, IDIBAPS, Barcelona, Spain.
  • Reig M; Department of Radiology, Hopital Beaujon, APHP. Nord, Clichy, France.
  • Ronot M; Université de Paris, CRI, INSERM, Paris, France.
Hepatology ; 76(5): 1318-1328, 2022 11.
Article en En | MEDLINE | ID: mdl-35349760
ABSTRACT
BACKGROUND &

AIMS:

The diagnostic accuracy of Liver Imaging Reporting and Data System (LI-RADS) v.2018 and European Association for the Study of the Liver (EASL) criteria for the diagnosis of HCC have been widely evaluated, but their reliability should be investigated. We aimed to assess and compare the reliability of LI-RADS v.2018 and EASL criteria for the diagnosis of HCC using MRI with extracellular contrast agents (ECAs) and gadoxetic acid (GA) and determine the effect of ancillary features on LI-RADS reliability. APPROACH &

RESULTS:

Ten readers reviewed MRI studies of 92 focal liver lesions measuring <3 cm acquired with ECAs and GA <1 month apart from two prospective trials, assessing EASL criteria, LI-RADS major and ancillary features, and LI-RADS categorization with and without including ancillary features. Inter-reader agreement for definite HCC diagnosis was substantial and similar for the two contrasts for both EASL and LI-RADS criteria. For ECA-MRI and GA-MRI, respectively, inter-reader agreement was k = 0.72 (95% CI, 0.63-0.81) and k = 0.72 (95% CI, 0.63-0.80); for nonrim hyperenhancement, k = 0.63 (95% CI, 0.54-0.72) and k = 0.57 (95% CI, 0.48-0.66); and for nonperipheral washout, k = 0.49 (95% CI, 0.40-0.59) and k = 0.48 (95% CI, 0.37-0.58) for enhancing capsule. The inter-reader agreement for LI-RADS after applying ancillary features remained in the same range of agreement.

CONCLUSIONS:

Agreement for definite HCC was substantial and similar for both scoring systems and the two contrast agents in small focal liver lesions. Agreement for LI-RADS categorization was lower for both contrast agents, and including LI-RADS ancillary features did not improve agreement.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article